Mayinglong Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001HN2
CNY
28.39
0.15 (0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
971.88
960.86
929.65
857.94
968.71
945.44
684.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
971.88
960.86
929.65
857.94
968.71
945.44
684.38
Raw Material Cost
509.63
498.20
545.47
473.59
522.14
494.59
447.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.20
1.27
3.36
0.00
3.02
1.94
3.11
Selling and Distribution Expenses
293.49
220.95
304.89
207.73
293.59
215.99
222.58
Other Expenses
1.44
1.57
1.04
1.51
1.26
1.31
1.59
Total Expenditure (Excl Depreciation)
819.75
736.16
864.16
696.40
831.32
725.64
688.84
Operating Profit (PBDIT) excl Other Income
152.10000000000002
224.7
65.5
161.5
137.4
219.8
-4.5
Other Income
14.61
18.33
32.51
19.54
27.41
20.04
34.52
Operating Profit (PBDIT)
189.97
267.07
117.42
201.61
180.25
261.28
45.41
Interest
2.20
1.27
3.36
0.00
3.02
1.94
3.11
Exceptional Items
9.43
5.14
0.26
0.73
-9.14
1.57
-0.55
Gross Profit (PBDT)
462.25
462.66
384.18
384.35
446.56
450.85
237.08
Depreciation
24.26
24.26
21.42
21.42
21.90
21.90
22.21
Profit Before Tax
172.94
246.68
92.91
180.93
146.19
239.01
19.53
Tax
26.33
36.59
12.50
32.51
27.12
37.12
-2.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
139.65
203.57
70.59
145.59
114.25
197.67
24.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
139.65
203.57
70.59
145.59
114.25
197.67
24.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.69
6.44
5.57
2.92
6.16
5.56
-3.41
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
147.34
210.01
76.16
148.52
120.40
203.22
21.46
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,141.64
4,269.49
4,065.96
4,000.71
3,855.18
3,912.99
3,737.97
Earnings per share (EPS)
0.32
0.47
0.16
0.34
0.27
0.46
0.06
Diluted Earnings per share
0.32
0.47
0.16
0.34
0.27
0.46
0.06
Operating Profit Margin (Excl OI)
15.55%
23.36%
6.83%
18.73%
13.52%
23.2%
-1.66%
Gross Profit Margin
20.29%
28.2%
12.3%
23.59%
17.35%
27.6%
6.1%
PAT Margin
14.37%
21.19%
7.59%
16.97%
11.79%
20.91%
3.63%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.14% vs 3.36% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -29.86% vs 175.59% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -29.47% vs 192.93% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 69.23% vs -61.76% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Mayinglong Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
971.88
0
971.88
Other Operating Income
0.00
0.00
0.00
Total Operating income
971.88
0
971.88
Raw Material Cost
509.63
0
509.63
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.20
0
2.20
Selling and Distribution Expenses
293.49
0
293.49
Other Expenses
1.44
0.00
1.44
Total Expenditure (Excl Depreciation)
819.75
0
819.75
Operating Profit (PBDIT) excl Other Income
152.13
0.00
152.13
Other Income
14.61
0
14.61
Operating Profit (PBDIT)
189.97
0
189.97
Interest
2.20
0
2.20
Exceptional Items
9.43
0
9.43
Gross Profit (PBDT)
462.25
0
462.25
Depreciation
24.26
0
24.26
Profit Before Tax
172.94
0
172.94
Tax
26.33
0
26.33
Provisions and contingencies
0
0
0.00
Profit After Tax
139.65
0
139.65
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
139.65
0
139.65
Share in Profit of Associates
0
0
0.00
Minority Interest
7.69
0
7.69
Other related items
0.00
0.00
0.00
Consolidated Net Profit
147.34
0
147.34
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,141.64
0
4,141.64
Earnings per share (EPS)
0.32
0
0.32
Diluted Earnings per share
0.32
0
0.32
Operating Profit Margin (Excl OI)
15.55%
0%
0.00
15.55%
Gross Profit Margin
20.29%
0%
0.00
20.29%
PAT Margin
14.37%
0%
0.00
14.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 97.19 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 1.14% vs 3.36% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.33% vs 20.91% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 14.73 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -29.86% vs 175.59% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 22.34% vs 15.55% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.54 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -29.47% vs 192.93% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.79% vs 42.01% in Jun 2024

Quarterly - Interest
Interest 0.22 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 69.23% vs -61.76% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -26.67% vs -28.57% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.55%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024